These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33315896)

  • 1. Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo.
    Snijders R; Fukinsia A; Claeys Y; Mpanya A; Hasker E; Meheus F; Miaka E; Boelaert M
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008832. PubMed ID: 33315896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo.
    Bessell PR; Lumbala C; Lutumba P; Baloji S; Biéler S; Ndung'u JM
    PLoS One; 2018; 13(9):e0204335. PubMed ID: 30240406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense].
    Lutumba P; Robays J; Miaka C; Kande V; Simarro PP; Shaw AP; Dujardin B; Boelaert M
    Trop Med Int Health; 2005 Apr; 10(4):347-56. PubMed ID: 15807799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis.
    Hasker E; Lutumba P; Mumba D; Lejon V; Büscher P; Kande V; Muyembe JJ; Menten J; Robays J; Boelaert M
    Am J Trop Med Hyg; 2010 Aug; 83(2):374-9. PubMed ID: 20682885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens.
    Lumbala C; Biéler S; Kayembe S; Makabuza J; Ongarello S; Ndung'u JM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006386. PubMed ID: 29590116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and implementation of a strategy for intensified screening for gambiense human African trypanosomiasis in Kongo Central province, DRC.
    Lumbala C; Kayembe S; Makabuza J; Lutumba P; Van Geertruyden JP; Bessell PR; Ndung'u JM
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008779. PubMed ID: 33057341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo.
    Davis CN; Rock KS; Antillón M; Miaka EM; Keeling MJ
    BMC Med; 2021 Apr; 19(1):86. PubMed ID: 33794881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
    Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
    Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo.
    Snijders R; Fukinsia A; Claeys Y; Hasker E; Mpanya A; Miaka E; Meheus F; Boelaert M
    Emerg Infect Dis; 2021 Aug; 27(8):2144-2153. PubMed ID: 34287133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.
    Robays J; Bilengue MM; Van der Stuyft P; Boelaert M
    Trop Med Int Health; 2004 May; 9(5):542-50. PubMed ID: 15117297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies.
    Inojosa WO; Augusto I; Bisoffi Z; Josenado T; Abel PM; Stich A; Whitty CJ
    BMJ; 2006 Jun; 332(7556):1479. PubMed ID: 16777858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study.
    Bisser S; Lumbala C; Nguertoum E; Kande V; Flevaud L; Vatunga G; Boelaert M; Büscher P; Josenando T; Bessell PR; Biéler S; Ndung'u JM
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004608. PubMed ID: 27058033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo.
    Lumbala C; Bessell PR; Lutumba P; Baloji S; Biéler S; Ndung'u JM
    PLoS One; 2017; 12(7):e0180555. PubMed ID: 28672036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.
    Mitashi P; Hasker E; Mbo F; Van Geertruyden JP; Kaswa M; Lumbala C; Boelaert M; Lutumba P
    Trop Med Int Health; 2015 Jan; 20(1):98-105. PubMed ID: 25329353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo.
    Antillon M; Huang CI; Crump RE; Brown PE; Snijders R; Miaka EM; Keeling MJ; Rock KS; Tediosi F
    Nat Commun; 2022 Feb; 13(1):1051. PubMed ID: 35217656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological, clinical and sociodemographic characteristics of human African trypanosomiasis (HAT) in and around Kinshasa, Democratic Republic of Congo].
    Tshimungu K; Okenge LN; Mukeba JN; Kande VB; De Mol P
    Sante; 2009; 19(2):73-80. PubMed ID: 20031514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A strategy to control Trypanosomiasis due to Trypanosoma brucei gambiense in an endemic region of Zaire. Association of a serological test and early treatment of suspected cases. Preliminary results].
    De Groof D; Bruneel H; Mungoma K; Ruppol JF
    Bull Soc Pathol Exot; 1993; 86(4):260-3. PubMed ID: 8292915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness.
    Castaño MS; Aliee M; Mwamba Miaka E; Keeling MJ; Chitnis N; Rock KS
    J Infect Dis; 2020 Jun; 221(Suppl 5):S539-S545. PubMed ID: 31876949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of different trypanosome species in the mid-guts of tsetse flies of the Malanga (Kimpese) sleeping sickness focus of the Democratic Republic of Congo.
    Simo G; Silatsa B; Flobert N; Lutumba P; Mansinsa P; Madinga J; Manzambi E; De Deken R; Asonganyi T
    Parasit Vectors; 2012 Sep; 5():201. PubMed ID: 22992486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.